You have 9 free searches left this month | for more free features.

City

Baltimore (1)

Houston (1)

Los Angeles (1)

New York (1)

Newport Beach (1)

Ottawa (1)

Philadelphia (1)

Toronto (1)

Worcester (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Intensity Therapeutics, Inc. (1)

Ottawa Hospital Research Institute (1)

Collaborator

Bristol-Myers Squibb (1)

Intensity Therapeutics, Inc. (1)

Merck Sharp & Dohme LLC (1)

Ontario Institute for Cancer Research (1)

Intervention

int230-6 (2)

anti-ctla-4 antibody (1)

anti-pd-1 antibody (1)

saline injection (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

int230-6

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting

Breast Cancer
+10 more

INT230-6
+2 more

Los Angeles, California
+7 more

Jun 21, 2022

Breast Cancer Trial in Ottawa (INT230-6, Saline injection)

Recruiting

Breast Cancer

INT230-6
Saline injection

Ottawa, Ontario, Canada

The Ottawa Hospital Research Institute and Cancer Center

Nov 9, 2021